Brevan Howard Capital Management’s Boston Scientific BSX Stock Holding History

Brevan Howard Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.94M	Sell	68,883 -102,685	-60%	-$5.58M	0.02%	561
2026 Q1	$10.8M	Sell	171,568 -29,188	-15%	-$2.33M	0.1%	122
2025 Q4	$19.2M	Buy	200,756 +126,912	+172%	+$12.4M	0.21%	72
2025 Q3	$7.21M	Sell	73,844 -4,055	-5%	-$420K	0.03%	170
2025 Q2	$8.37M	Sell	77,899 -10,220	-12%	-$1.03M	0.05%	227
2025 Q1	$8.89M	Sell	88,119 -9,221	-9%	-$929K	0.09%	68
2024 Q4	$8.69M	Buy	97,340 +64,489	+196%	+$5.68M	0.06%	80
2024 Q3	$2.75M	Buy	32,851 +19,331	+143%	+$1.52M	0.02%	211
2024 Q2	$1.04M	Buy	+13,520	New	+$990K	0.01%	360

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brevan Howard Capital Management's BSX Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Boston Scientific (BSX) stake by 60% in Q2 2026, selling an estimated $5.58M and leaving 68,883 shares worth $2.94M. The position accounts for 0.02% of the portfolio, ranked #561.

Brevan Howard Capital Management first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $19.2M in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Brevan Howard Capital Management held 68,883 shares of Boston Scientific worth $2.94M as of Q2 2026.
Brevan Howard Capital Management sold 102,685 Boston Scientific shares in Q2 2026, an estimated $5.58M.
Boston Scientific made up 0.02% of Brevan Howard Capital Management's portfolio in Q2 2026, its #561 holding.
Brevan Howard Capital Management first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
Brevan Howard Capital Management's Boston Scientific position peaked at $19.2M in Q4 2025.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.